Global Antivenom Market Growth 2020-2025
According to this study, over the next five years the Antivenom market will register a 4.3%% CAGR in terms of revenue, the global market size will reach $ 1032.7 million by 2025, from $ 871.8 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antivenom business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Antivenom market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Antivenom, covering the supply chain analysis, impact assessment to the Antivenom market size growth rate in several scenarios, and the measures to be undertaken by Antivenom companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Polyvalent antivenom
Monovalent antivenom
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Non-profit Institutions
Hospitals and Clinic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CSL
Serum Biotech
Merck
Pfizer
Haffkine Bio-Pharmaceutical
BTG
Vins Bioproducts
Rare Disease Therapeutics
Bharat Serums and Vaccines
Flynn Pharma
MicroPharm
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Antivenom consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Antivenom market by identifying its various subsegments.
Focuses on the key global Antivenom manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antivenom with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Antivenom submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antivenom Consumption 2015-2025
2.1.2 Antivenom Consumption CAGR by Region
2.2 Antivenom Segment by Type
2.2.1 Polyvalent antivenom
2.2.2 Monovalent antivenom
2.3 Antivenom Consumption by Type
2.3.1 Global Antivenom Consumption Market Share by Type (2015-2020)
2.3.2 Global Antivenom Revenue and Market Share by Type (2015-2020)
2.3.3 Global Antivenom Sale Price by Type (2015-2020)
2.4 Antivenom Segment by Application
2.4.1 Non-profit Institutions
2.4.2 Hospitals and Clinic
2.5 Antivenom Consumption by Application
2.5.1 Global Antivenom Consumption Market Share by Type (2015-2020)
2.5.2 Global Antivenom Value and Market Share by Type (2015-2020)
2.5.3 Global Antivenom Sale Price by Type (2015-2020)
3 Global Antivenom by Company
3.1 Global Antivenom Sales Market Share by Company
3.1.1 Global Antivenom Sales by Company (2018-2020)
3.1.2 Global Antivenom Sales Market Share by Company (2018-2020)
3.2 Global Antivenom Revenue Market Share by Company
3.2.1 Global Antivenom Revenue by Company (2018-2020)
3.2.2 Global Antivenom Revenue Market Share by Company (2018-2020)
3.3 Global Antivenom Sale Price by Company
3.4 Global Antivenom Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Antivenom Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Antivenom Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Antivenom by Regions
4.1 Antivenom by Regions
4.2 Americas Antivenom Consumption Growth
4.3 APAC Antivenom Consumption Growth
4.4 Europe Antivenom Consumption Growth
4.5 Middle East & Africa Antivenom Consumption Growth
5 Americas
5.1 Americas Antivenom Consumption by Countries
5.1.1 Americas Antivenom Consumption by Countries (2015-2020)
5.1.2 Americas Antivenom Value by Countries (2015-2020)
5.2 Americas Antivenom Consumption by Type
5.3 Americas Antivenom Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Antivenom Consumption by Regions
6.1.1 APAC Antivenom Consumption by Regions (2015-2020)
6.1.2 APAC Antivenom Value by Regions (2015-2020)
6.2 APAC Antivenom Consumption by Type
6.3 APAC Antivenom Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Antivenom by Countries
7.1.1 Europe Antivenom Consumption by Countries (2015-2020)
7.1.2 Europe Antivenom Value by Countries (2015-2020)
7.2 Europe Antivenom Consumption by Type
7.3 Europe Antivenom Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Antivenom by Countries
8.1.1 Middle East & Africa Antivenom Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Antivenom Value by Countries (2015-2020)
8.2 Middle East & Africa Antivenom Consumption by Type
8.3 Middle East & Africa Antivenom Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Antivenom Distributors
10.3 Antivenom Customer
11 Global Antivenom Market Forecast
11.1 Global Antivenom Consumption Forecast (2021-2025)
11.2 Global Antivenom Forecast by Regions
11.2.1 Global Antivenom Forecast by Regions (2021-2025)
11.2.2 Global Antivenom Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Antivenom Forecast by Type
11.8 Global Antivenom Forecast by Application
12 Key Players Analysis
12.1 CSL
12.1.1 Company Information
12.1.2 Antivenom Product Offered
12.1.3 CSL Antivenom Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 CSL Latest Developments
12.2 Serum Biotech
12.2.1 Company Information
12.2.2 Antivenom Product Offered
12.2.3 Serum Biotech Antivenom Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Serum Biotech Latest Developments
12.3 Merck
12.3.1 Company Information
12.3.2 Antivenom Product Offered
12.3.3 Merck Antivenom Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Merck Latest Developments
12.4 Pfizer
12.4.1 Company Information
12.4.2 Antivenom Product Offered
12.4.3 Pfizer Antivenom Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Haffkine Bio-Pharmaceutical
12.5.1 Company Information
12.5.2 Antivenom Product Offered
12.5.3 Haffkine Bio-Pharmaceutical Antivenom Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Haffkine Bio-Pharmaceutical Latest Developments
12.6 BTG
12.6.1 Company Information
12.6.2 Antivenom Product Offered
12.6.3 BTG Antivenom Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 BTG Latest Developments
12.7 Vins Bioproducts
12.7.1 Company Information
12.7.2 Antivenom Product Offered
12.7.3 Vins Bioproducts Antivenom Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Vins Bioproducts Latest Developments
12.8 Rare Disease Therapeutics
12.8.1 Company Information
12.8.2 Antivenom Product Offered
12.8.3 Rare Disease Therapeutics Antivenom Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Rare Disease Therapeutics Latest Developments
12.9 Bharat Serums and Vaccines
12.9.1 Company Information
12.9.2 Antivenom Product Offered
12.9.3 Bharat Serums and Vaccines Antivenom Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Bharat Serums and Vaccines Latest Developments
12.10 Flynn Pharma
12.10.1 Company Information
12.10.2 Antivenom Product Offered
12.10.3 Flynn Pharma Antivenom Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Flynn Pharma Latest Developments
12.11 MicroPharm
12.11.1 Company Information
12.11.2 Antivenom Product Offered
12.11.3 MicroPharm Antivenom Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 MicroPharm Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Antivenom Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Polyvalent antivenom
Table 5. Major Players of Monovalent antivenom
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Antivenom Consumption Market Share by Type (2015-2020)
Table 8. Global Antivenom Revenue by Type (2015-2020) ($ million)
Table 9. Global Antivenom Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Antivenom Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Antivenom Consumption Market Share by Application (2015-2020)
Table 13. Global Antivenom Value by Application (2015-2020)
Table 14. Global Antivenom Value Market Share by Application (2015-2020)
Table 15. Global Antivenom Sale Price by Application (2015-2020)
Table 16. Global Antivenom Sales by Company (2017-2019) (K Vials)
Table 17. Global Antivenom Sales Market Share by Company (2017-2019)
Table 18. Global Antivenom Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Antivenom Revenue Market Share by Company (2017-2019)
Table 20. Global Antivenom Sale Price by Company (2017-2019)
Table 21. Global Antivenom Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Antivenom Products Offered
Table 23. Antivenom Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Antivenom Consumption by Regions 2015-2020 (K Vials)
Table 25. Global Antivenom Consumption Market Share by Regions 2015-2020
Table 26. Global Antivenom Value by Regions 2015-2020 ($ Millions)
Table 27. Global Antivenom Value Market Share by Regions 2015-2020
Table 28. Americas Antivenom Consumption by Countries (2015-2020) (K Vials)
Table 29. Americas Antivenom Consumption Market Share by Countries (2015-2020)
Table 30. Americas Antivenom Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Antivenom Value Market Share by Countries (2015-2020)
Table 32. Americas Antivenom Consumption by Type (2015-2020) (K Vials)
Table 33. Americas Antivenom Consumption Market Share by Type (2015-2020)
Table 34. Americas Antivenom Consumption by Application (2015-2020) (K Vials)
Table 35. Americas Antivenom Consumption Market Share by Application (2015-2020)
Table 36. APAC Antivenom Consumption by Countries (2015-2020) (K Vials)
Table 37. APAC Antivenom Consumption Market Share by Countries (2015-2020)
Table 38. APAC Antivenom Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Antivenom Value Market Share by Regions (2015-2020)
Table 40. APAC Antivenom Consumption by Type (2015-2020) (K Vials)
Table 41. APAC Antivenom Consumption Market Share by Type (2015-2020)
Table 42. APAC Antivenom Consumption by Application (2015-2020) (K Vials)
Table 43. APAC Antivenom Consumption Market Share by Application (2015-2020)
Table 44. Europe Antivenom Consumption by Countries (2015-2020) (K Vials)
Table 45. Europe Antivenom Consumption Market Share by Countries (2015-2020)
Table 46. Europe Antivenom Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Antivenom Value Market Share by Countries (2015-2020)
Table 48. Europe Antivenom Consumption by Type (2015-2020) (K Vials)
Table 49. Europe Antivenom Consumption Market Share by Type (2015-2020)
Table 50. Europe Antivenom Consumption by Application (2015-2020) (K Vials)
Table 51. Europe Antivenom Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Antivenom Consumption by Countries (2015-2020) (K Vials)
Table 53. Middle East & Africa Antivenom Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Antivenom Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Antivenom Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Antivenom Consumption by Type (2015-2020) (K Vials)
Table 57. Middle East & Africa Antivenom Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Antivenom Consumption by Application (2015-2020) (K Vials)
Table 59. Middle East & Africa Antivenom Consumption Market Share by Application (2015-2020)
Table 60. Antivenom Distributors List
Table 61. Antivenom Customer List
Table 62. Global Antivenom Consumption Forecast by Countries (2021-2025) (K Vials)
Table 63. Global Antivenom Consumption Market Forecast by Regions
Table 64. Global Antivenom Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Antivenom Value Market Share Forecast by Regions
Table 66. Global Antivenom Consumption Forecast by Type (2021-2025) (K Vials)
Table 67. Global Antivenom Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Antivenom Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Antivenom Value Market Share Forecast by Type (2021-2025)
Table 70. Global Antivenom Consumption Forecast by Application (2021-2025) (K Vials)
Table 71. Global Antivenom Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Antivenom Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Antivenom Value Market Share Forecast by Application (2021-2025)
Table 74. CSL Product Offered
Table 75. CSL Antivenom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 76. CSL Main Business
Table 77. CSL Latest Developments
Table 78. CSL Basic Information, Company Total Revenue (in $ million), Antivenom Manufacturing Base, Sales Area and Its Competitors
Table 79. Serum Biotech Product Offered
Table 80. Serum Biotech Antivenom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 81. Serum Biotech Main Business
Table 82. Serum Biotech Latest Developments
Table 83. Serum Biotech Basic Information, Company Total Revenue (in $ million), Antivenom Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Product Offered
Table 85. Merck Antivenom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Merck Basic Information, Company Total Revenue (in $ million), Antivenom Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Product Offered
Table 90. Pfizer Antivenom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Pfizer Basic Information, Company Total Revenue (in $ million), Antivenom Manufacturing Base, Sales Area and Its Competitors
Table 94. Haffkine Bio-Pharmaceutical Product Offered
Table 95. Haffkine Bio-Pharmaceutical Antivenom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 96. Haffkine Bio-Pharmaceutical Main Business
Table 97. Haffkine Bio-Pharmaceutical Latest Developments
Table 98. Haffkine Bio-Pharmaceutical Basic Information, Company Total Revenue (in $ million), Antivenom Manufacturing Base, Sales Area and Its Competitors
Table 99. BTG Product Offered
Table 100. BTG Antivenom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 101. BTG Main Business
Table 102. BTG Latest Developments
Table 103. BTG Basic Information, Company Total Revenue (in $ million), Antivenom Manufacturing Base, Sales Area and Its Competitors
Table 104. Vins Bioproducts Product Offered
Table 105. Vins Bioproducts Basic Information, Company Total Revenue (in $ million), Antivenom Manufacturing Base, Sales Area and Its Competitors
Table 106. Vins Bioproducts Main Business
Table 107. Vins Bioproducts Latest Developments
Table 108. Vins Bioproducts Antivenom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 109. Rare Disease Therapeutics Product Offered
Table 110. Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 111. Rare Disease Therapeutics Main Business
Table 112. Rare Disease Therapeutics Latest Developments
Table 113. Rare Disease Therapeutics Basic Information, Company Total Revenue (in $ million), Antivenom Manufacturing Base, Sales Area and Its Competitors
Table 114. Bharat Serums and Vaccines Product Offered
Table 115. Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 116. Bharat Serums and Vaccines Main Business
Table 117. Bharat Serums and Vaccines Latest Developments
Table 118. Bharat Serums and Vaccines Basic Information, Company Total Revenue (in $ million), Antivenom Manufacturing Base, Sales Area and Its Competitors
Table 119. Flynn Pharma Product Offered
Table 120. Flynn Pharma Antivenom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 121. Flynn Pharma Main Business
Table 122. Flynn Pharma Latest Developments
Table 123. Flynn Pharma Basic Information, Company Total Revenue (in $ million), Antivenom Manufacturing Base, Sales Area and Its Competitors
Table 124. MicroPharm Product Offered
Table 125. MicroPharm Antivenom Sales (K Vials), Revenue ($ Million), Price (USD/Vial) and Gross Margin (2018-2020E)
Table 126. MicroPharm Main Business
Table 127. MicroPharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. MicroPharm Latest Developments
List of Figures
Figure 1. Picture of Antivenom
Figure 2. Antivenom Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Antivenom Consumption Growth Rate 2015-2025 (K Vials)
Figure 5. Global Antivenom Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Polyvalent antivenom
Figure 7. Product Picture of Monovalent antivenom
Figure 8. Global Antivenom Consumption Market Share by Type (2015-2020)
Figure 9. Global Antivenom Value Market Share by Type (2015-2020)
Figure 10. Antivenom Consumed in Non-profit Institutions
Figure 11. Global Antivenom Market: Non-profit Institutions (2015-2020) (K Vials)
Figure 12. Global Antivenom Market: Non-profit Institutions (2015-2020) ($ Millions)
Figure 13. Antivenom Consumed in Hospitals and Clinic
Figure 14. Global Antivenom Market: Hospitals and Clinic (2015-2020) (K Vials)
Figure 15. Global Antivenom Market: Hospitals and Clinic (2015-2020) ($ Millions)
Figure 16. Global Antivenom Consumption Market Share by Application (2015-2020)
Figure 17. Global Antivenom Value Market Share by Application (2015-2020)
Figure 18. Global Antivenom Sales Market Share by Company in 2017
Figure 19. Global Antivenom Sales Market Share by Company in 2019
Figure 20. Global Antivenom Revenue Market Share by Company in 2017
Figure 21. Global Antivenom Revenue Market Share by Company in 2019
Figure 22. Global Antivenom Sale Price by Company in 2019
Figure 23. Global Antivenom Consumption Market Share by Regions 2015-2020
Figure 24. Global Antivenom Value Market Share by Regions 2015-2020
Figure 25. Americas Antivenom Consumption 2015-2020 (K Vials)
Figure 26. Americas Antivenom Value 2015-2020 ($ Millions)
Figure 27. APAC Antivenom Consumption 2015-2020 (K Vials)
Figure 28. APAC Antivenom Value 2015-2020 ($ Millions)
Figure 29. Europe Antivenom Consumption 2015-2020 (K Vials)
Figure 30. Europe Antivenom Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Antivenom Consumption 2015-2020 (K Vials)
Figure 32. Middle East & Africa Antivenom Value 2015-2020 ($ Millions)
Figure 33. Americas Antivenom Consumption Market Share by Countries in 2019
Figure 34. Americas Antivenom Value Market Share by Countries in 2019
Figure 35. Americas Antivenom Consumption Market Share by Type in 2019
Figure 36. Americas Antivenom Consumption Market Share by Application in 2019
Figure 37. United States Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 38. United States Antivenom Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 40. Canada Antivenom Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 42. Mexico Antivenom Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Antivenom Consumption Market Share by Countries in 2019
Figure 44. APAC Antivenom Value Market Share by Regions in 2019
Figure 45. APAC Antivenom Consumption Market Share by Type in 2019
Figure 46. APAC Antivenom Consumption Market Share by Application in 2019
Figure 47. China Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 48. China Antivenom Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 50. Japan Antivenom Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 52. Korea Antivenom Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 54. Southeast Asia Antivenom Value Growth 2015-2020 ($ Millions)
Figure 55. India Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 56. India Antivenom Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 58. Australia Antivenom Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Antivenom Consumption Market Share by Countries in 2019
Figure 60. Europe Antivenom Value Market Share by Countries in 2019
Figure 61. Europe Antivenom Consumption Market Share by Type in 2019
Figure 62. Europe Antivenom Consumption Market Share by Application in 2019
Figure 63. Germany Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 64. Germany Antivenom Value Growth 2015-2020 ($ Millions)
Figure 65. France Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 66. France Antivenom Value Growth 2015-2020 ($ Millions)
Figure 67. UK Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 68. UK Antivenom Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 70. Italy Antivenom Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 72. Russia Antivenom Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Antivenom Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Antivenom Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Antivenom Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Antivenom Consumption Market Share by Application in 2019
Figure 77. Egypt Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 78. Egypt Antivenom Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 80. South Africa Antivenom Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 82. Israel Antivenom Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 84. Turkey Antivenom Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Antivenom Consumption Growth 2015-2020 (K Vials)
Figure 86. GCC Countries Antivenom Value Growth 2015-2020 ($ Millions)
Figure 87. Global Antivenom Consumption Growth Rate Forecast (2021-2025) (K Vials)
Figure 88. Global Antivenom Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Antivenom Consumption 2021-2025 (K Vials)
Figure 90. Americas Antivenom Value 2021-2025 ($ Millions)
Figure 91. APAC Antivenom Consumption 2021-2025 (K Vials)
Figure 92. APAC Antivenom Value 2021-2025 ($ Millions)
Figure 93. Europe Antivenom Consumption 2021-2025 (K Vials)
Figure 94. Europe Antivenom Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Antivenom Consumption 2021-2025 (K Vials)
Figure 96. Middle East & Africa Antivenom Value 2021-2025 ($ Millions)
Figure 97. United States Antivenom Consumption 2021-2025 (K Vials)
Figure 98. United States Antivenom Value 2021-2025 ($ Millions)
Figure 99. Canada Antivenom Consumption 2021-2025 (K Vials)
Figure 100. Canada Antivenom Value 2021-2025 ($ Millions)
Figure 101. Mexico Antivenom Consumption 2021-2025 (K Vials)
Figure 102. Mexico Antivenom Value 2021-2025 ($ Millions)
Figure 103. Brazil Antivenom Consumption 2021-2025 (K Vials)
Figure 104. Brazil Antivenom Value 2021-2025 ($ Millions)
Figure 105. China Antivenom Consumption 2021-2025 (K Vials)
Figure 106. China Antivenom Value 2021-2025 ($ Millions)
Figure 107. Japan Antivenom Consumption 2021-2025 (K Vials)
Figure 108. Japan Antivenom Value 2021-2025 ($ Millions)
Figure 109. Korea Antivenom Consumption 2021-2025 (K Vials)
Figure 110. Korea Antivenom Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Antivenom Consumption 2021-2025 (K Vials)
Figure 112. Southeast Asia Antivenom Value 2021-2025 ($ Millions)
Figure 113. India Antivenom Consumption 2021-2025 (K Vials)
Figure 114. India Antivenom Value 2021-2025 ($ Millions)
Figure 115. Australia Antivenom Consumption 2021-2025 (K Vials)
Figure 116. Australia Antivenom Value 2021-2025 ($ Millions)
Figure 117. Germany Antivenom Consumption 2021-2025 (K Vials)
Figure 118. Germany Antivenom Value 2021-2025 ($ Millions)
Figure 119. France Antivenom Consumption 2021-2025 (K Vials)
Figure 120. France Antivenom Value 2021-2025 ($ Millions)
Figure 121. UK Antivenom Consumption 2021-2025 (K Vials)
Figure 122. UK Antivenom Value 2021-2025 ($ Millions)
Figure 123. Italy Antivenom Consumption 2021-2025 (K Vials)
Figure 124. Italy Antivenom Value 2021-2025 ($ Millions)
Figure 125. Russia Antivenom Consumption 2021-2025 (K Vials)
Figure 126. Russia Antivenom Value 2021-2025 ($ Millions)
Figure 127. Spain Antivenom Consumption 2021-2025 (K Vials)
Figure 128. Spain Antivenom Value 2021-2025 ($ Millions)
Figure 129. Egypt Antivenom Consumption 2021-2025 (K Vials)
Figure 130. Egypt Antivenom Value 2021-2025 ($ Millions)
Figure 131. South Africa Antivenom Consumption 2021-2025 (K Vials)
Figure 132. South Africa Antivenom Value 2021-2025 ($ Millions)
Figure 133. Israel Antivenom Consumption 2021-2025 (K Vials)
Figure 134. Israel Antivenom Value 2021-2025 ($ Millions)
Figure 135. Turkey Antivenom Consumption 2021-2025 (K Vials)
Figure 136. Turkey Antivenom Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Antivenom Consumption 2021-2025 (K Vials)
Figure 138. GCC Countries Antivenom Value 2021-2025 ($ Millions)
Figure 139. CSL Antivenom Market Share (2018-2020)
Figure 140. Serum Biotech Antivenom Market Share (2018-2020)
Figure 141. Merck Antivenom Market Share (2018-2020)
Figure 142. Pfizer Antivenom Market Share (2018-2020)
Figure 143. Haffkine Bio-Pharmaceutical Antivenom Market Share (2018-2020)
Figure 144. BTG Antivenom Market Share (2018-2020)
Figure 145. Vins Bioproducts Antivenom Market Share (2018-2020)
Figure 146. Rare Disease Therapeutics Antivenom Market Share (2018-2020)
Figure 147. Bharat Serums and Vaccines Antivenom Market Share (2018-2020)
Figure 148. Flynn Pharma Antivenom Market Share (2018-2020)
Figure 149. MicroPharm Antivenom Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets